Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Transtema in conjunction with a rights issue
Mandate

Vinge has advised Transtema in conjunction with a rights issue

October 09, 2018 Capital Markets and Public M&A

Vinge has advised Transtema in connection with a rights issue.

The issue proceeds of approximately MSEK 78 will be used for a part financing in the acquisition of Ericsson Local Services as well as to facilitate future growth efforts.

The prospectus was approved by the Swedish Financial Supervisory Authority on 14 September 2018 and the subscription period expired on 1 October 2018.

Vinge’s team primarily consisted of Anders Strid, Wibeke Sorling, Natalie Bäck and corporate assistant Camilla Andersson.
 

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025